Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of genotyping in non-small cell lung cancer treatment: current status.

Drugs - 3 Dec 2011

Bonanno Laura, Favaretto Adolfo, Rugge Massimo, Taron Miquel, Rosell Rafael

Abstract excerpt

Non-small cell lung cancer (NSCLC) is a common malignant disease with an extremely poor prognosis. Chemotherapeutic treatment for advanced disease is currently based on histological subtyping, but recent discoveries of genetic alterations in subsets of NSCLC have already changed clinical practice with regard to Egfr mutations as predictive markers of response to gefitinib and erlotinib. This has also paved the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Genotype
Share to Genotyping Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Precision Medicine

Source

Identifiers

PMID: 22085382
DOI: 10.2165/11597700-000000000-00000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of genotyping in non-small cell lung cancer treatment: current status.PMID 22085382Read ↗

Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.Semantic proximity Read ↗

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular TypingSemantic proximity Read ↗

Application of Plasma Genotyping Technologies in Non–Small Cell Lung Cancer: A Practical ReviewSemantic proximity Read ↗

Personalizing therapy in advanced non-small cell lung cancer.Semantic proximity Read ↗

Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Semantic proximity Read ↗

The impact of genomic changes on treatment of lung cancer.Semantic proximity Read ↗

Genotyping of EGFR Mutations from Bronchial Cytological Specimens in Slovakian Lung Cancer Patients.Semantic proximity Read ↗

Novel SNP improves differential survivability and mortality in non-small cell lung cancer patients.Semantic proximity Read ↗

Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis.Semantic proximity Read ↗

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerSemantic proximity Read ↗

Usefulness of predictive tests for cancer treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.